TR199902888A3 - Yeni eritromisin türevleri, hazirlanmalari, ilaç olarak kullanimlari. - Google Patents

Yeni eritromisin türevleri, hazirlanmalari, ilaç olarak kullanimlari.

Info

Publication number
TR199902888A3
TR199902888A3 TR1999/02888A TR9902888A TR199902888A3 TR 199902888 A3 TR199902888 A3 TR 199902888A3 TR 1999/02888 A TR1999/02888 A TR 1999/02888A TR 9902888 A TR9902888 A TR 9902888A TR 199902888 A3 TR199902888 A3 TR 199902888A3
Authority
TR
Turkey
Prior art keywords
medicines
preparation
erythromycin derivatives
new erythromycin
new
Prior art date
Application number
TR1999/02888A
Other languages
English (en)
Turkish (tr)
Other versions
TR199902888A2 (xx
Inventor
Denis Alexis
Original Assignee
Hoechst Marion Roussel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel filed Critical Hoechst Marion Roussel
Publication of TR199902888A2 publication Critical patent/TR199902888A2/xx
Publication of TR199902888A3 publication Critical patent/TR199902888A3/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
TR1999/02888A 1998-11-24 1999-11-24 Yeni eritromisin türevleri, hazirlanmalari, ilaç olarak kullanimlari. TR199902888A3 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9814782A FR2786188B1 (fr) 1998-11-24 1998-11-24 Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments

Publications (2)

Publication Number Publication Date
TR199902888A2 TR199902888A2 (xx) 2000-06-21
TR199902888A3 true TR199902888A3 (tr) 2000-06-21

Family

ID=9533122

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/02888A TR199902888A3 (tr) 1998-11-24 1999-11-24 Yeni eritromisin türevleri, hazirlanmalari, ilaç olarak kullanimlari.

Country Status (24)

Country Link
US (2) US6440941B1 (enExample)
EP (1) EP1004592B1 (enExample)
JP (1) JP2000159790A (enExample)
KR (1) KR100587445B1 (enExample)
CN (1) CN1165546C (enExample)
AR (1) AR021388A1 (enExample)
AT (1) ATE245160T1 (enExample)
AU (1) AU772171B2 (enExample)
BR (1) BR9905735A (enExample)
CA (1) CA2290136C (enExample)
DE (1) DE69909577T2 (enExample)
DK (1) DK1004592T3 (enExample)
ES (1) ES2198867T3 (enExample)
FR (1) FR2786188B1 (enExample)
HU (1) HUP9904392A3 (enExample)
IL (1) IL133101A (enExample)
MX (1) MXPA99010813A (enExample)
NO (1) NO314729B1 (enExample)
PL (1) PL336736A1 (enExample)
PT (1) PT1004592E (enExample)
RU (1) RU2237672C2 (enExample)
TR (1) TR199902888A3 (enExample)
TW (1) TWI247747B (enExample)
ZA (1) ZA997176B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
DK1147121T3 (da) * 1999-01-27 2004-04-13 Pfizer Prod Inc Ketolidantibiotika
EE200100613A (et) 1999-05-24 2003-02-17 Pfizer Products Inc. 13-metüülerütromütsiini derivaadid
EP1167376B1 (en) 2000-06-30 2004-07-14 Pfizer Products Inc. Macrolide antibiotics
US7601695B2 (en) 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
FR2862647B1 (fr) * 2003-11-25 2008-07-04 Aventis Pharma Sa Derives de pyrazolyle, procede de preparation et intermediaires de ce procede a titre de medicaments et de compositions pharmaceutiques les renfermant
WO2006080954A1 (en) * 2004-07-28 2006-08-03 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
AU2008316830B2 (en) 2007-10-25 2016-03-17 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
US8552162B2 (en) * 2008-05-09 2013-10-08 Enanta Pharmaceuticals, Inc. Processes for the preparation of 2 fluoro 6-11 bicyclic erythromycin derivatives
CN107854477A (zh) 2008-10-24 2018-03-30 森普拉制药公司 使用含三唑的大环内酯治疗抗性疾病的方法
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
US9480679B2 (en) 2009-09-10 2016-11-01 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
HRP20160168T1 (hr) 2010-03-22 2016-03-25 Cempra Pharmaceuticals Inc Kristalne forme makrolida i njihova uporaba
BR112012029586A2 (pt) 2010-05-20 2016-08-02 Cempra Pharmaceuticals Inc processos para preparar macrolídeos e cetolídeos e intermediários dos mesmos
KR20130120458A (ko) * 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
BR112013009823A2 (pt) 2010-10-22 2016-07-05 Bayer Ip Gmbh novos compostos heterocíclicos como pesticidas
WO2013148891A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
WO2014152326A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
AU2014233240B2 (en) 2013-03-15 2018-08-09 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
CN106432383A (zh) * 2016-09-14 2017-02-22 重庆两江药物研发中心有限公司 索利霉素及其中间体的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4182895A (en) * 1976-12-20 1980-01-08 Sterling Drug Inc. 1-Amino-lower-alkyl-3,4-diphenyl-1H-pyrazoles
CA1098527A (en) * 1976-12-20 1981-03-31 Denis M. Bailey 1-amino-lower-alkyl-3,4-diphenyl-1h-pyrazoles
JPH04234891A (ja) * 1990-03-05 1992-08-24 Fujisawa Pharmaceut Co Ltd 新規セフェム化合物およびその塩
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
KR20010013660A (ko) * 1997-06-11 2001-02-26 실버스타인 아써 에이. 9-옥심 에리트로마이신 유도체
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments

Also Published As

Publication number Publication date
NO995745D0 (no) 1999-11-23
EP1004592B1 (fr) 2003-07-16
TWI247747B (en) 2006-01-21
NO314729B1 (no) 2003-05-12
IL133101A (en) 2007-02-11
EP1004592A1 (fr) 2000-05-31
CA2290136C (fr) 2010-07-20
MXPA99010813A (es) 2005-09-08
KR100587445B1 (ko) 2006-06-08
DK1004592T3 (da) 2003-10-27
PL336736A1 (en) 2000-06-05
US6440941B1 (en) 2002-08-27
ES2198867T3 (es) 2004-02-01
TR199902888A2 (xx) 2000-06-21
FR2786188A1 (fr) 2000-05-26
DE69909577T2 (de) 2004-06-03
CA2290136A1 (fr) 2000-05-24
AR021388A1 (es) 2002-07-17
AU5952299A (en) 2000-05-25
ATE245160T1 (de) 2003-08-15
RU2237672C2 (ru) 2004-10-10
ZA997176B (en) 2000-11-20
HUP9904392A3 (en) 2001-08-28
DE69909577D1 (de) 2003-08-21
BR9905735A (pt) 2000-08-08
NO995745L (no) 2000-05-25
HU9904392D0 (en) 2000-01-28
CN1263101A (zh) 2000-08-16
KR20000057017A (ko) 2000-09-15
PT1004592E (pt) 2003-12-31
US20030050254A1 (en) 2003-03-13
HUP9904392A2 (hu) 2000-05-28
AU772171B2 (en) 2004-04-08
IL133101A0 (en) 2001-03-19
FR2786188B1 (fr) 2002-10-31
JP2000159790A (ja) 2000-06-13
US6664398B2 (en) 2003-12-16
CN1165546C (zh) 2004-09-08

Similar Documents

Publication Publication Date Title
DE50014425D1 (de) Asymmetrischer, mehrstrahliger radarsensor
ZA200007638B (en) Pyrazoline derivatives, their preparation and application as medicaments.
IS1865B (is) Nýjar erýþrómýsin afleiður, sem og læknislyf sem innihalda þær
ZA200107983B (en) New compounds, their preparation and use.
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
TR199601002A1 (tr) 2-Okzo- ve 2-thio-1, 2-dihidrokinolinil-oksazolidinonlar.
MXPA03000078A (es) Derivados de purina.
DE60019577D1 (de) 4, 5, 6, 7-tetrahydroindazolderivate als antitumormittel
MA26601A1 (fr) Derives 2-(purin-9yl)-tetrahydrofurant-3,4-diol .
TR199600664A2 (tr) 11-(ikameli fenil)-estra-4, 9-dien türevleri.
DK0941998T3 (da) 3,6-ketalmakrolidantibiotika
IS5527A (is) Nýjar erýþrómýsín afleiður
TR199802624A3 (tr) Yeni farmasötik.
DK1015467T3 (da) 6,9-brobundne erythromycinderivater
HUP0104035A3 (en) Novel erythromycin derivatives, preparation method and use as medicines
ATE239750T1 (de) 6,11-verbrückte erythromycinderivate
DK1004592T3 (da) Nye erythromycinderivater, deres fremstilling og deres anvendelse som medikamenter
ZA200204814B (en) Substituted phenyl-piperazine derivatives, their preparation and use.
DE50107988D1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
EE200000447A (et) 1,3,4-oksadiasolooni derivaadid
NO20004015L (no) Biretningsmessig, fremstillbar, løftegenererende maskestang
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
DE69906149D1 (de) 4,5-azolo-oxindole
ITBO990671A0 (it) Maniglione antipanico.
TR199900285A3 (tr) Yeni eritromisin türevleri ve bunlari içeren ilaçlar.